Max Schlaak - Dissemin

Dissemin is shutting down on January 1st, 2025

Language
Login

All papers authored by Max Schlaak

This paper was not found in any repository, but could be made available legally by the author.

2024 Achim Hekler, Roman C. Maron, Sarah Haggenmüller, Max Schmitt, Christoph Wies, Jochen S. Utikal, Friedegund Meier, Sarah Hobelsberger, Frank F. Gellrich, Mildred Sergon, Axel Hauschild, Lars E. French, Lucie Heinzerling, Justin G. Schlager, Kamran Ghoreschi and 16 other authors

Using multiple real-world dermoscopic photographs of one lesion improves melanoma classification via deep learning

Upload

This paper was not found in any repository, but could be made available legally by the author.

2023 Jürgen C. Becker, Selma Ugurel, Ulrike Leiter, Friedegund Meier, Ralf Gutzmer, Sebastian Haferkamp, Lisa Zimmer, Elisabeth Livingstone, Thomas K. Eigentler, Axel Hauschild, Felix Kiecker, Jessica C. Hassel, Peter Mohr, Michael Fluck, Ioannis Thomas and 45 other authors

Adjuvant immunotherapy with nivolumab versus observation in completely resected Merkel cell carcinoma (ADMEC-O): disease-free survival results from a randomised, open-label, phase 2 trial

Upload

This paper was not found in any repository, but could be made available legally by the author.

Elias A. T. Koch, Anne Petzold, Anja Wessely, Edgar Dippel, Markus Eckstein, Anja Gesierich, Ralf Gutzmer, Jessica C. Hassel, Harald Knorr, Nicole Kreuzberg, Ulrike Leiter, Carmen Loquai, Friedegund Meier, Markus Meissner, Peter Mohr and 11 other authors

Liver-directed treatment is associated with improved survival and increased response to immune checkpoint blockade in metastatic uveal melanoma: results from a retrospective multicenter trial

Upload

This paper is made freely available by the publisher.

Sebastian Mönch, Maurice M. Heimer, Michael Winkelmann, Anne Guertler, Max Schlaak

ORCID

, Amanda Tufman, Najib Ben Khaled, Enrico de Toni, Christoph B. Westphalen, Michael von Bergwelt-Baildon, Julien Dinkel, Philipp M. Kazmierczak, Michael Ingrisch, Nabeel Mansour, Marcus Unterrainer and 3 other authors

Patterns of pseudoprogression across different cancer entities treated with immune checkpoint inhibitors

Download from doi.org

This paper is made freely available by the publisher.

Zhe Peng, Bernhard Gillissen

ORCID

, Antje Richter, Tobias Sinnberg, Max S. Schlaak

ORCID

, Jürgen Eberle

ORCID

Enhanced Apoptosis and Loss of Cell Viability in Melanoma Cells by Combined Inhibition of ERK and Mcl-1 Is Related to Loss of Mitochondrial Membrane Potential, Caspase Activation and Upregulation of Proapoptotic Bcl-2 Proteins

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

Raphael Bodensohn, Simone Werner, Jonas Reis, Montserrat Pazos Escudero, Anna-Lena Kaempfel, Indrawati Hadi, Robert Forbrig, Farkhad Manapov, Stefanie Corradini, Claus Belka, Sebastian Theurich, Lucie Heinzerling, Max Schlaak

ORCID

, Maximilian Niyazi

Stereotactic radiosurgery and combined immune checkpoint therapy with ipilimumab and nivolumab in patients with melanoma brain metastases: A retrospective monocentric toxicity analysis

Upload

This paper is made freely available by the publisher.

Ephsona Shencoru, Max Schlaak

ORCID

Klinische und diagnostische Besonderheiten bei Hautkrebs auf dunklerer Haut

Download from link.springer.com

This paper is made freely available by the publisher.

Alexander Urbanski, Julia Minnemann, Cornelia Mauch, Thomas Schmidt, Nicole Kreuzberg, Max Schlaak

ORCID

, Christiane J. Bruns, Dirk L. Stippel, Roger Wahba

Oligometastatic disease and visceral resections in advanced malignant melanoma: a propensity-matched analysis

Download from link.springer.com

This paper is made freely available by the publisher.

2022 Katharina Schumann, Cornelia Mauch, Kai‐Christian Klespe, Carmen Loquai, Ulrike Nikfarjam, Max Schlaak

ORCID

, Larissa Akçetin, Peter Kölblinger, Magdalena Hoellwerth, Markus Meissner, Guelcin Mengi, Andreas Dominik Braun, Miriam Mengoni, Reinhard Dummer

ORCID

, Joanna Mangana and 53 other authors

Real‐world outcomes using PD ‐1 antibodies and BRAF + MEK inhibitors for adjuvant melanoma treatment from 39 skin cancer centers in Germany, Austria and Switzerland

Download from onlinelibrary.wiley.com

This paper is made freely available by the publisher.

Alexander Thiem

ORCID

, Pegah Mashhadiakbar, Christiane Cussigh, Jessica C. Hassel, Imke Grimmelmann, Ralf Gutzmer, Max Schlaak

ORCID

, Markus V. Heppt

ORCID

, Pia Dücker, Svea Hüning, Lena Schulmeyer, Bastian Schilling

ORCID

, Sebastian Haferkamp, Mirjana Ziemer

ORCID

, Rose K. C. Moritz and 8 other authors

Immune checkpoint inhibition and targeted therapy for melanoma: A patient‐oriented cross‐sectional comparative multicentre study

Download from onlinelibrary.wiley.com

This paper is made freely available by the publisher.

Leonie Müller-Jensen, Sarah Zierold, Judith M. Versluis, Wolfgang Boehmerle, Petra Huehnchen, Matthias Endres, Raphael Mohr, Annette Compter, Christian U. Blank, Tim Hagenacker, Friedegund Meier, Lydia Reinhardt, Anja Gesierich, Martin Salzmann, Jessica C. Hassel and 18 other authors

Dataset of a retrospective multicenter cohort study on characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

Leonie Müller-Jensen, Sarah Zierold, Judith M. Versluis

ORCID

, Wolfgang Boehmerle

ORCID

, Petra Huehnchen, Matthias Endres

ORCID

, Raphael Mohr, Annette Compter, Christian U. Blank, Tim Hagenacker

ORCID

, Friedegund Meier

ORCID

, Lydia Reinhardt, Anja Gesierich, Martin Salzmann

ORCID

, Jessica C. Hassel

ORCID

and 18 other authors

Characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis: A retrospective multicentre cohort study

Upload

This paper was not found in any repository, but could be made available legally by the author.

Roman C. Maron, Achim Hekler, Sarah Haggenmüller, Christof von Kalle, Jochen S. Utikal, Verena Müller, Maria Gaiser, Friedegund Meier

ORCID

, Sarah Hobelsberger

ORCID

, Frank F. Gellrich, Mildred Sergon

ORCID

, Axel Hauschild

ORCID

, Lars E. French, Lucie Heinzerling, Justin G. Schlager and 18 other authors

Model soups improve performance of dermoscopic skin cancer classifiers

Upload

This paper was not found in any repository, but could be made available legally by the author.

M. Kinberger, F. Ghoreschi, R. Moritz, M. Schlaak

ORCID

, K. Meier, G. Dobos

Primary cutaneous gamma-delta lymphoma responding only to mogamulizumab and total skin electron beam therapy

Upload

This paper was not found in any repository, but could be made available legally by the author.

R. Cankaya, S. Schulz, R. Moritz, F. Walter, M. Schlaak

ORCID

, T. Eigentler, G. Dobos

Skin directed therapy superior to systemic treatment in primary cutaneous B-cell lymphoma? A study from the Charité cutaneous lymphoma registry on time to next treatment

Upload

This paper was not found in any repository, but could be made available legally by the author.

M. Schlaak

ORCID

, R. Dummer, J. M. Kirkwood, A. Joshua, M. Milhem, L. Gastaud, C. Mauch, M. L. Yushak, S. Lockwood, C. Hayes, A. N. Shoushtari

821P Safety and efficacy of infrequent tebentafusp treatment omissions in patients with metastatic uveal melanoma

Upload

This paper was not found in any repository, but could be made available legally by the author.

S. Schulz, R. Cankaya, F. Walter, R. Moritz, M. Schlaak

ORCID

, T. Eigentler, G. Dobos

Time to next treatment in early-stage mycosis fungoides: a retrospective study from the Charité cutaneous lymphoma registry

Upload

This paper was not found in any repository, but could be made available legally by the author.

M. Zidane, R. Moritz, U. Reidel, M. Schlaak

ORCID

, G. Dobos

Durable complete remission in Sézary syndrome using extracorporal photopheresis: the role of maintenance treatment on a case series

Upload

This paper is made freely available by the publisher.

Dirk Tomsitz

ORCID

, Max Schlaak

ORCID

, Sarah Zierold, Giulia Pesch, Thomas U. Schulz, Genoveva Müller, Christine Zecha, Lars E. French, Lucie Heinzerling

Development of Lymphopenia during Therapy with Immune Checkpoint Inhibitors Is Associated with Poor Outcome in Metastatic Cutaneous Melanoma

Download from doi.org

This paper is made freely available by the publisher.

Ryan J. Sullivan, Mohammed M. Milhem, Lev V. Demidov, Karl D. Lewis, Max Schlaak

ORCID

, Sophie Piperno-Neumann, Shaad Essa Abdullah, Claire Watkins, Howard Goodall, John M. Kirkwood

Treatment with tebentafusp beyond radiographic progressive disease (PD) in metastatic uveal melanoma (mUM).

Download from doi.org

Missing publications? Search for publications with a matching author name.